PHAS   $0.0533  -26.21% Market Closed

PhaseBio Pharmaceuticals Inc
Last Events:

2022-11-02 Trend pattern changed from Not found to расходящийся клин с наклоном вниз.

2022-11-01 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2022-10-29 Trend pattern changed from сужающийся канал to Not found.

2022-10-29 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

2022-10-28 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: exit from the overbought zone.

2022-10-27 Trend pattern changed from расходящийся клин с наклоном вниз to сужающийся канал.

2022-10-26 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2022-10-26 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.


Current temperature: 2.12
ST: 0, Cor:

50-50 Year Forecast
Low with 51% probability: 0.04
Target: 1.00
High with 47% probability: 0.27
Analyst Recommendations:
Number of estimates 1
Target Price Mean 1.00
Mean unverified/preliminary 1.00 / 1.00
Target Price Low / High 1.00 / 1.00
Median / STD DEV 1.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell Sell Sell
stoch Sell Sell -
ma20 Sell - -
ma50 Sell - -
ma100 Sell - -
Candlestick PatternOct. 27, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US7172241090
ceo Mr. Jonathan P. Mow MBA
Website https://phasebio.com
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.